XML 66 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Investments (Details 4) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net sales $ 483,045 $ 701,719
Gross profit 464,329 681,582
Share of losses from investments accounted for using the equity method (40,589)
BioFirst [Member]    
Net sales 257,235 43,975
Gross profit 10,121 (37,160)
Net loss (5,401,074) (972,303)
Share of losses from investments accounted for using the equity method (1,168,733) (210,086)
Rgene [Member]    
Net sales 16,595
Gross profit (335,735)
Net loss (641,636) (53,877)
Share of losses from investments accounted for using the equity method